Goldenwell Biotech, Inc. — Income Charts
8 quarters of history · ending 2025-09-30 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Income Breakdown
Revenue
$0
Cost of Revenue
$0
Gross Profit
$25K
SG&A
—
Operating Income↑+71.9% +$15K
$-6K
EBITDA↑+71.9% +$15K
$-6K
Interest Expense↑+0.0% +$0
$2K
Interest Income
—
Other Income/Expense
$0
Pretax Income↓-10.7% -$3K
$-34K
Tax Provision
$0
Net Income↓-134.6% -$31K
$-8K
Gross Margin
50.4%
Operating Margin
-34402.9%
Net Margin
35913.7%
Effective Tax Rate↑+0.0pts
0.0%
Deferred Tax Assets
$0
DTA Valuation Allowance↑+34.7% +$2K
$6K
NOL Carryforwards↓-65.4% -$15K
$8K
ETR Federal Statutory↑+0.0pts
21.0%
Operating Lease Cost
—
Revenue YoY Variation↓-50.4pts
-100.0%
Income YoY Variation↑+31.1pts
71.9%
Revenue QoQ Variation
-100.0%
Income QoQ Variation↓-144.8pts
-88.6%